Fingerprint
Dive into the research topics of 'A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
A phase I trial of immunotherapy with lapuleucel-T (APC8024) in patients with refractory metastatic tumors that express HER-2/neu
Prema P. Peethambaram, Michelle E. Melisko, Kristine J. Rinn, Steven R. Alberts, Nicole M. Provost, Lori A. Jones, Robert B. Sims, Lisa R.C. Lin, Mark W. Frohlich, John W. Park
Research output: Contribution to journal › Article › peer-review
50
Scopus
citations